Showing results (5151-5160 of 5,717) with videos related to

Sort By:
Pageof 572
BMC Nephrology|April 1, 2017
Association of IL1 beta gene polymorphism and allograft functions in renal transplant recipients :a case control study from Kashmir ValleyMohammad Ashraf Bhat, Manzoor Ahmad Parry, Saniya Nissar, et al.
BMC Nephrology|March 7, 2019
Prevalence and factors associated with renal dysfunction in children admitted to two hospitals in northwestern TanzaniaNeema Chami, Rogatus Kabyemera, Tulla Masoza, et al.
BMC Nephrology|March 3, 2019
Increased concentrations of platelet- and endothelial-derived microparticles in patients with myocardial infarction and reduced renal function- a descriptive studyJosefin Mörtberg, Kristina Lundwall, Fariborz Mobarrez, et al.
BMC Nephrology|March 2, 2017
Relationship between history of coronary heart disease at dialysis initiation and onset of events associated with heart disease: a propensity-matched analysis of a prospective cohort studyDaijo Inaguma, Shigehisa Koide, Kazuo Takahashi, et al.
BMC Nephrology|March 2, 2017
Gaps and barriers in health-care provision for co-morbid diabetes and chronic kidney disease: a cross-sectional studyC Lo, H Teede, G Fulcher, et al.
BMC Nephrology|February 22, 2017
Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteriaJ Koeze, F Keus, W Dieperink, et al.
BMC Nephrology|February 22, 2017
β-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranesCarlo Donadio, Danika Tognotti, Laura Caponi, et al.
BMC Nephrology|February 22, 2017
Ultrafiltration rate is an important determinant of microcirculatory alterations during chronic renal replacement therapyGerke Veenstra, Andrius Pranskunas, Inga Skarupskiene, et al.
BMC Nephrology|February 22, 2017
Biomarkers for the detection of renal fibrosis and prediction of renal outcomes: a systematic reviewSherry G Mansour, Jeremy Puthumana, Steven G Coca, et al.
BMC Nephrology|February 17, 2017
Risedronate therapy in patients with mild-to-moderate chronic kidney disease with osteoporosis: post-hoc analysis of data from the risedronate phase III clinical trialsTakashi Shigematsu, Ryoichi Muraoka, Toshitsugu Sugimoto, et al.
Pageof 572